Clinical Trial Update: Effectiveness of Tofacitinib in Systemic Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the effectiveness of tofacitinib in systemic sclerosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Efficacy of Tofacitinib in the Systemic Sclerosis | Phase 2 | Status: UNKNOWN